CD274 and non-small cell lung carcinoma: However, we did not evaluate the direct mechanisms by which serum CYFRA 21-1 levels were associated with worse prognosis in patients with NSCLC treated with anti-PD-1/PD-L1 antibodies, a limitation of our study.